Clinical trial
A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the…
NCT00421603 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00421603 |
|---|---|
| Title | A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence |
| Acronym | TACT |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Adderall-XR and Topiramate, Placebo |
| Enrollment | 81 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jan 12, 2007 |
| Last update posted | Apr 24, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: